- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05160181
Impact of Yogotherapeutics on Chronic Pains' Patients (YOGADO)
Impact of Yogotherapeutics in Consultation on Chronic Pains' Patients
연구 개요
상세 설명
Yoga is a discipline that has its origins in India for nearly 5,000 years, and which aims to bring physical, mental and spiritual well-being through postures, stretching, breathing exercises and meditation.
Non-invasive and having very few side effects, this approach allows the practitioner to reclaim their body, to know themselves better, to accept their limits, to respect them and to empower themselves in their care and pathology.
More and more studies are now looking at the positive effect of yoga whether it is on stress by demonstrating the drop in cortisol in participants, or on the reduction of symptoms of depression, improvement of immune function, or pain.
To our knowledge, no study of the impact of yoga for analgesic treatment has been carried out in France.
Through this retrospective study, the investigators wish to demonstrate a reduction in pain and / or an improvement in the quality of life.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Pontoise, 프랑스, 95300
- Departement of Chronic Pain Consultation, Hospital René Dubos,
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Patient ≥ 18 years old,
- Seen in consultation for chronic pain with implementation of Yogatherapy,
Exclusion Criteria:
- Patient < 18 years old,
- No indication for Yogatherapy treatment (Severe cognitive disorder / Major unbalanced psychological disorder),
- Trauma pathology and / or acute fracture in progress,
- Patient refusal to participate.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Yogatherapy
Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
|
Description: Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Evolution of the patient's pain
기간: Between the 1st and the 5th consultation, an average of 3 to 5 month
|
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the 5th consultation, using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
|
Between the 1st and the 5th consultation, an average of 3 to 5 month
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Evolution of the patient's pain over time
기간: Between the 1st and the 5th consultation, an average of 3 to 5 month
|
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the last consultation (number 10 maximum), using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
|
Between the 1st and the 5th consultation, an average of 3 to 5 month
|
|
Improvement of patient's sleep
기간: Between the 1st and the last consultation, an average of 5 to 10 month
|
The impact of pain on sleep is evaluated by questioning the patient at the first and last consultation (number 10 maximum) The answer to the question is YES or NO
|
Between the 1st and the last consultation, an average of 5 to 10 month
|
|
Evolution of the patient's quality of life
기간: Between the 1st and the last consultation, an average of 5 to 10 month
|
The quality of life is assessed at all visits, by questioning patient, on the following elements: work, daily activities, mood…. to obtain a score on a numerical scale between 0 and 10 Results are interpreted as following : EN ≤ 5 = Very degraded, 6 ≥ EN ≤ 7 = Degraded and EN > 7 = Normal) |
Between the 1st and the last consultation, an average of 5 to 10 month
|
|
Evolution of the patient's therapeutic
기간: Between the 1st and the last consultation, an average of 5 to 10 month
|
The evolution of the therapeutic is evaluated by questioning the patient at the first and last consultation (number 10 maximum) about their treatment: treatment name, indication, dosage, number of doses per day, decrease or increase for each treatment ……. to see if there is a decrease or not in the patient's therapies.
|
Between the 1st and the last consultation, an average of 5 to 10 month
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Jocelyne BOREL-KUHNER, Hospital René Dubos,
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .